Correlation Between Diagnos Laboratorium and Sarana Meditama
Can any of the company-specific risk be diversified away by investing in both Diagnos Laboratorium and Sarana Meditama at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diagnos Laboratorium and Sarana Meditama into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diagnos Laboratorium Utama and Sarana Meditama Metropolitan, you can compare the effects of market volatilities on Diagnos Laboratorium and Sarana Meditama and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diagnos Laboratorium with a short position of Sarana Meditama. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diagnos Laboratorium and Sarana Meditama.
Diversification Opportunities for Diagnos Laboratorium and Sarana Meditama
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Diagnos and Sarana is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Diagnos Laboratorium Utama and Sarana Meditama Metropolitan in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarana Meditama Metr and Diagnos Laboratorium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diagnos Laboratorium Utama are associated (or correlated) with Sarana Meditama. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarana Meditama Metr has no effect on the direction of Diagnos Laboratorium i.e., Diagnos Laboratorium and Sarana Meditama go up and down completely randomly.
Pair Corralation between Diagnos Laboratorium and Sarana Meditama
Assuming the 90 days trading horizon Diagnos Laboratorium Utama is expected to generate 1.43 times more return on investment than Sarana Meditama. However, Diagnos Laboratorium is 1.43 times more volatile than Sarana Meditama Metropolitan. It trades about -0.04 of its potential returns per unit of risk. Sarana Meditama Metropolitan is currently generating about -0.25 per unit of risk. If you would invest 23,400 in Diagnos Laboratorium Utama on September 4, 2024 and sell it today you would lose (800.00) from holding Diagnos Laboratorium Utama or give up 3.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Diagnos Laboratorium Utama vs. Sarana Meditama Metropolitan
Performance |
| Timeline |
| Diagnos Laboratorium |
| Sarana Meditama Metr |
Diagnos Laboratorium and Sarana Meditama Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Diagnos Laboratorium and Sarana Meditama
The main advantage of trading using opposite Diagnos Laboratorium and Sarana Meditama positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diagnos Laboratorium position performs unexpectedly, Sarana Meditama can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarana Meditama will offset losses from the drop in Sarana Meditama's long position.| Diagnos Laboratorium vs. Prodia Widyahusada Tbk | Diagnos Laboratorium vs. Medikaloka Hermina PT | Diagnos Laboratorium vs. Itama Ranoraya | Diagnos Laboratorium vs. Digital Mediatama Maxima |
| Sarana Meditama vs. Surya Citra Media | Sarana Meditama vs. Sawit Sumbermas Sarana | Sarana Meditama vs. Mitra Pinasthika Mustika | Sarana Meditama vs. Jakarta Int Hotels |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |